Vitamin C and E supplements improve the impaired antioxidant status and decrease plasma lipid peroxides in hemodialysis patients

Journal of Nutritional Biochemistry

Volumn 13, Issue 11, 2002, Pages 653-663

  Chao, Jane C J ^a   Yuan, Mi Duo ^a   Chen, Pei Yuan ^a   Chien, Shiaw Wen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antioxidant status; Hemodialysis; Lipid peroxidation; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; LIPID PEROXIDE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIPID BLOOD LEVEL; MALE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0036849415     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00209-7     Document Type: Article

References (39)

1. Ceballos-Picot I., Witko-Sarsat V., Merad-Boudia M., Nguyen A.T., Thevenin M., Jaudon M.C., Zingraff J., Verger C., Junger P., Descamps-Latscha B. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic. Biol. Med. 21:1996;845-853.
2. Schmidtmann S., Muller M., von Baehr R., Precht K. Changes of antioxidative homeostasis in patients on chronic haemodialysis. Nephrol. Dial. Transplant. 6:(Suppl):1991;71-74.
3. McGrath L.T., Douglas A.F., McClean E., Brown J.H., Doherty C.C., Johnston G.D., Archbold G.P. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin. Chim. Acta. 235:1995;179-188.
4. Fiorillo C., Oliviero C., Rizzuti G., Nediani C., Pacini A., Nassi P. Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis. Clin. Chem. Lab. Med. 36:1998;149-153.
5. Galli F., Varga Z., Balla J., Ferraro B., Canestrari F., Floridi A., Kakuk G., Buoncristiani U. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int. 59:(Suppl 78):2001;S148-S154.
6. Morena M., Cristol J.P., Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif. 18:2000;191-199.
7. Clermont G., Lecour S., Lahet J., Siohan P., Vergely C., Chevet D., Rifle G., Rochette L. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients a possible explanation for the increased cardiovascular risk in these patients . Cardiovas. Res. 47:2000;618-623.
8. Ha T.K.K., Sattar N., Talwar D., Cooney J., Simpson K., O'Reilly D.St.J., Lean M.E.J. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. Q. J. Med. 89:1996;765-769.
9. Jackson P., Loughrey C.M., Lightbody J.H., McNamee P.T., Young I.S. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin. Chem. 41:1995;1135-1138.
10. Hultqvist M., Hegbrant J., Nilsson-Thorell C., Lindholm T., Nillson P., Lindén T., Hultqvist-Bengtsson U. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin. Nephrol. 47:1997;37-46.
11. Durak I., Akyol O., Basesme E., Canbolat O., Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 66:1994;76-80.
12. Shurtz-Swirski R., Mashiach E., Kristal B., Shkolnik T., Shasha S.M. Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure. Nephron. 71:1995;176-179.
13. Chen C.K., Liaw J.M., Juang J.G., Lin T.H. Antioxidant enzymes and trace elements in hemodialyzed patients. Biol. Trace Elem. Res. 58:1997;149-157.
14. Canestrari F., Buoncristiani U., Galli F., Giorgini A., Albertini M.C., Carobi C., Pascucci M., Bossu M. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis. Clin. Chim. Acta. 234:1995;127-136.
15. Mohora M., Mircescu G., Cirjan C., Mihailescu I., Girneata L., Ursea N., Dinu V. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Roman J. Intern. Med. 33:1995;237-242.
16. Toborek M., Wasik T., Drozdz M., Klin M., Magner-Wrobel K., Kopieczna-Grzebieniak E. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metab. Clin. Exp. 41:1992;1229-1232.
17. Paul J.L., Sall N.D., Soni T., Poignet J.L., Lindenbaum A., Man N.K., Moatti N., Raichvarg D. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron. 64:1993;106-109.
18. Peuchant E., Delmas-Beauvieux M.-C., Dubourg L., Thomas M.-J., Perromat A., Aparicio M., Clerc M., Combe C. Antioxidant effects of a supplemented very low protein diet in chronic renal failure. Free Radic. Biol. Med. 22:1997;313-320.
19. Makoff R. Vitamin replacement therapy in renal failure patients. Miner. Electrolyte Metab. 25:1999;349-351.
20. Ono K. Reduction of osmotic hemodialysis and anemia by high dose vitamin E supplementation in regular haemodialysis patients. Proc. Eur. Dial Transplant Assoc.-Eur. Renal Assoc. 21:1985;296-299.
21. Yeksan M., Polat M., Turk S., Kazanci H., Akhan G., Erdogan Y., Erkul I. Effect of vitamin E therapy on sexual functions of uremic patients in hemodialysis. Int. J. Artif. Organs. 15:1992;648-652.
22. Yalcin A.S., Yurtkuran M., Dilek K., Kilinc A., Taga Y., Emerk K. The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients. Clin. Chim. Acta. 185:1989;109-112.
23. Yukawa S., Hibino A., Maeda T., Mimura K., Yukawa A., Maeda A., Kishino M., Sonobe M., Mune M., Yamada Y. Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients. Nephrol. Dial. Transplant. 10:(Suppl):1995;1-3.
24. Kacem B., Marshall M.R., Mattews R.F., Gregory J.F. Simultaneous analysis of ascorbic acid and dehydroascorbic acid by HPLC with post-column derivatization and UV absorbance. J. Agric. Food Chem. 34:1986;271-274.
25. Cheng H.-H., Guo D.-C., Shieh M.-J. Altered bioavailability of β -carotene in rats fed diets containing cholesterol and soybean oil or lard. Food Sci. Agric. Chem. 1:1999;237-243.
26. Anderson M.E. Enzymatic and chemical methods for the determination of glutathione. Dolphin D., et al. Glutathione Chemical, Biochemical and Medical Aspects, vol A . 1989;339-365 John Wiley and Sons, New York, NY.
27. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A, A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84:1993;407-412.
28. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products malonaldehyde and 4-hydroxynonenal . Methods Enzymol. 186:1990;407.
29. Food and Nutrition Board, Institute of Medicine, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. 2000;National Academy Press, Washington, DC.
30. Costello J.F., Sadovnic M.J., Cottington E.M. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal. J. Am. Soc. Nephrol. 1:1991;1289-1298.
31. Ono K. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients. Clin. Nephrol. 26:1986;239-243.
32. Morgan S.H., Maher E.R., Purkiss P., Watts R.W., Curtis J.R. Oxalate metabolism in end-stage renal disease the effect of ascorbic acid and pyridoxine . Nephrol. Dial. Transplant. 3:1998;28-32.
33. Tomson C.R., Channon S.M., Ward M.K., Laker M.F. Ascorbate-induced hyperoxalaemia has no significant effect on lactate generation or erythrocyte 2,3, diphosphoglycerate in dialysis patients. Eur. J. Clin. Invest. 20:1990;411-415.
34. Rolton H.A., McConnell K.M., Modi K.S., Macdougall A.I. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis. Nephrol. Dial. Transplant. 6:1991;440-443.
35. Graumlich J.F., Ludden T.M., Conry-Cantilena C. Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion. Pharm. Res. 14:1997;1133-1139.
36. Levine M., Conry-Cantilena C., Wang Y., Welch R.W., Washko P.W., Dhariwal K.R., Park J.B., Lazarev A., Graumlich J.F., King J., Cantilena L.R. Vitamin C pharmacokinetics in healthy volunteers evidence for a recommended dietary allowance . Proc. Natl. Acad. Sci. U.S.A. 93:1996;3704-3709.
37. Hornig D. Metabolism and requirements of ascorbic acid in man. South Africa Med. J. 60:1981;818-823.
38. Blanchard J. Depletion and repletion kinetics of vitamin C in humans. J. Nutr. 121:1991;170-176.
39. Pastor M.C., Sierra C., Bonal J., Teixido J. Serum and erythrocyte tocopherol in uremic patients effect of hemodialysis versus peritoneal dialysis . Am. J. Nephrol. 13:1993;238-243.